Analystreport

Protagonist Therapeutics (NASDAQ:PTGX) was downgraded by analysts at Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com